BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35753289)

  • 21. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
    Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
    Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study.
    Hyrcza MD; Martins-Filho SN; Spatz A; Wang HJ; Purgina BM; Desmeules P; Park PC; Bigras G; Jung S; Cutz JC; Xu Z; Berman DM; Sheffield BS; Cheung CC; Leduc C; Hwang DM; Ionescu D; Klonowski P; Chevarie-Davis M; Chami R; Lo B; Stockley TL; Tsao MS; Torlakovic E
    Mod Pathol; 2024 Jan; 37(1):100384. PubMed ID: 37972928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.
    Cheng CT; Chen YY; Wu RC; Tsai CY; Chiang KC; Yeh TS; Chen MH; Yeh CN
    Oncol Rep; 2018 Sep; 40(3):1411-1421. PubMed ID: 30015968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for
    Macerola E; Proietti A; Poma AM; Vignali P; Sparavelli R; Ginori A; Basolo A; Elisei R; Santini F; Basolo F
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
    Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
    Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan.
    Suzuki H; Isaji S; Pairojkul C; Uttaravichien T
    J Hepatobiliary Pancreat Surg; 2000; 7(2):206-11. PubMed ID: 10982615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value.
    Tian X; Wang Q; Li Y; Hu J; Wu L; Ding Q; Zhang C
    Pathol Oncol Res; 2015 Jan; 21(1):195-201. PubMed ID: 24985031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.
    Kamlua S; Patrakitkomjorn S; Jearanaikoon P; Menheniott TR; Giraud AS; Limpaiboon T
    Oncol Rep; 2012 Apr; 27(4):1207-12. PubMed ID: 22159958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.
    Zhang KJ; Zhang BY; Zhang KP; Tang LM; Liu SS; Zhu DM; Zhang DL
    World J Gastroenterol; 2010 May; 16(20):2554-7. PubMed ID: 20503457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma.
    Kojima S; Hisaka T; Midorikawa R; Naito Y; Akiba J; Tanigawa M; Yano H; Akagi Y; Okuda K
    Anticancer Res; 2020 Aug; 40(8):4749-4754. PubMed ID: 32727801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in differentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis.
    Dechaphunkul A; Kanngurn S; Dechsukhum C; Tanutit P; Khow-Ean U; Sunpaweravong P
    J Med Assoc Thai; 2010 May; 93(5):523-8. PubMed ID: 20524437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infection.
    Mordvinov VA; Minkova GA; Kovner AV; Ponomarev DV; Lvova MN; Zaparina O; Romanenko SA; Shilov AG; Pakharukova MY
    Life Sci; 2021 Jul; 277():119494. PubMed ID: 33862109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
    Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
    J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.